Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Abstract

The new guideline aims to encourage the implementation of evidence-based practice and improve the national average 5-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."